Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: MI NONMETROPOLITAN AREA — October 2026
Nonmetro Michigan's shrinking workforce meets a scientific talent premium.
Biostatistician pay in the metro reached $153,353 against a national $131,958, even as Michigan's nonmetro labor force contracted roughly 3.2% year-over-year.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Nonmetro MI labor force change: -3.2% — Year-over-year decline, compounding talent scarcity
- Michigan unemployment rate: 5.0% — vs 4.1% national rate, September 2026
- Biopharma quit rate: 1.9% — National rate signals limited voluntary turnover
- Lab/R&D vacancy rate: 23.2% — Top 13 U.S. life sci markets, Q1 2026
Key takeaways
Nonmetro labor supply is shrinking faster than demand.
A 3.2% year-over-year drop in Michigan's nonmetro labor force, against a national quit rate of just 1.9% in life sciences, means fewer available workers and fewer willing to move. Headcount plans built on local hiring assumptions from even a year ago likely overstate available supply.
Biostatistician and Research Scientist pay point to a widening specialist premium.
Metro advertised medians of $153,353 and $144,686 run meaningfully above national medians of $131,958 and $130,339, consistent with employers paying up for scarce analytical and scientific talent amid broad inflation. Compensation benchmarking should track this gap role-by-role; metro premiums vary and should not be assumed uniform.
Regulatory Affairs and Clinical Data Manager pay softening deserves scrutiny.
Both roles show moderate declines locally ($104,144 and $126,904) even as national regulatory affairs demand is described as acute and credential-driven. A local pay pullback alongside persistent national scarcity may reflect fewer, lower-leveled postings, so this pattern is worth checking against actual time-to-fill data before adjusting offers downward.
Michigan's stalled BioTalent Connect program removes a planned supply fix.
Halting of the $645M Michigan Strategic Fund workforce program before 2026 launch delays pipeline-building for manufacturing, quality, and clinical roles statewide. Nonmetro employers most dependent on local training infrastructure absorb this gap most directly, with no near-term public-sector alternative visible.
Median advertised pay by role — MI NONMETROPOLITAN AREA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist | $109,700 | $144,686 | $158,188 | Significant increase | $130,339 |
| Clinical Research Associate | $81,168 | $98,423 | $107,514 | Stable | $90,065 |
| Lab Technician | $37,175 | $44,720 | $45,760 | Moderate increase | $47,840 |
| Regulatory Affairs Specialist | $71,414 | $104,144 | $110,788 | Moderate decline | $103,780 |
| Clinical Data Manager | $96,750 | $126,904 | $146,400 | Moderate decline | $123,653 |
| Biostatistician | $111,745 | $153,353 | $156,770 | Significant increase | $131,958 |
| Validation Engineer * | $82,514 | $110,300 | $120,327 | Significant increase | $106,478 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Nonmetropolitan Michigan's labor force contracted roughly 3.2% year-over-year, compounding a statewide unemployment rate of 5.0% that sits nearly a full point above the national rate, which signals a shrinking candidate pool amid steady demand. Rural distance from Michigan's bioscience hubs around Grand Rapids and Ann Arbor compounds the scarcity for credentialed scientific and regulatory talent, forcing nonmetro employers to compete against better-resourced urban and out-of-state employers for the same limited pipeline.
What it means
Shrinking nonmetro labor supply, layered onto a national life sciences environment where quit rates sit at just 1.9% and lab/R&D vacancy ran as high as 23.2% in Q1, means experienced hires in regulatory affairs, quality, and clinical operations will take longer to fill and cost more to retain outside Michigan's metro clusters. Build-vs-outsource calculus shifts further toward CRO and CDMO partnerships for nonmetro sites that cannot realistically sustain a local bench of senior scientific or regulatory staff. Consider reviewing whether nonmetro-based R&D, quality, or clinical roles can be restructured as remote-eligible or hybrid to pull from the broader Michigan and national labor pool and reduce dependence on a contracting local market.
Looking ahead
Early indicator: Watch whether Michigan's continued labor force decline (down 26,000 statewide in September alone) extends into nonmetro counties specifically, which would further tighten an already thin rural scientific and technical talent pool.
Emerging pressure point: Track whether Regulatory Affairs and Clinical Data Manager advertised pay softening locally persists through November, or reverses as national scarcity in these functions reasserts itself in metro postings.
Potential inflection point: Follow any state-level successor to the halted MI BioTalent Connect funding; its absence shapes whether nonmetro employers can rely on public workforce development or must fund training internally.
Worth watching: Monitor CRO/CDMO capacity announcements in Michigan and neighboring states, since nonmetro sites facing recruiting friction for CRA and biomanufacturing roles may accelerate outsourcing decisions this quarter.
Sources
- Michigan Dept. of Labor and Economic Opportunity — Michigan's nonmetro labor force declined roughly 3.2% year-over-year
- Bureau of Labor Statistics — Michigan's September unemployment rate of 5.0%, 0.8-0.9 points above U.S. rate
- Life sciences industry labor market research — Lab/R&D vacancy reached 23.2% across top 13 U.S. life sciences markets in Q1 2026
- Industry labor market survey data — National biopharma quit rate sits at 1.9%
- Michigan Strategic Fund — MI BioTalent Connect $645M workforce program halted before 2026 launch
- Michigan Dept. of Labor and Economic Opportunity — Michigan's labor force declined 26,000 during September
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.